181 related articles for article (PubMed ID: 25366523)
1. The effects of hyaluronic acid vaginal gel on the vaginal epithelium of ovariectomized rats.
Liu SB; Liu SL; Gan XL; Zhou Q; Hu LN
Gynecol Endocrinol; 2015 Mar; 31(3):208-13. PubMed ID: 25366523
[TBL] [Abstract][Full Text] [Related]
2. Comparative uterine effects on ovariectomized rats after repeated treatment with different vaginal estrogen formulations.
López-Belmonte J; Nieto C; Estevez J; Delgado JL; del Prado JM
Maturitas; 2012 Aug; 72(4):353-8. PubMed ID: 22683083
[TBL] [Abstract][Full Text] [Related]
3. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?
Stute P
Arch Gynecol Obstet; 2013 Dec; 288(6):1199-201. PubMed ID: 24178484
[TBL] [Abstract][Full Text] [Related]
4. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.
Lima SM; Bernardo BF; Yamada SS; Reis BF; da Silva GM; Galvão MA
Maturitas; 2014 Jul; 78(3):205-11. PubMed ID: 24856055
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial.
Chen J; Geng L; Song X; Li H; Giordan N; Liao Q
J Sex Med; 2013 Jun; 10(6):1575-84. PubMed ID: 23574713
[TBL] [Abstract][Full Text] [Related]
6. The effect of oxytocin vaginal gel on vaginal atrophy in postmenopausal women: a randomized controlled trial.
Zohrabi I; Abedi P; Ansari S; Maraghi E; Shakiba Maram N; Houshmand G
BMC Womens Health; 2020 May; 20(1):108. PubMed ID: 32429977
[TBL] [Abstract][Full Text] [Related]
7. Non-hormonal treatment of vulvo-vaginal atrophy-related symptoms in post-menopausal women.
Tersigni C; Di Simone N; Tempestilli E; Cianfrini F; Russo R; Moruzzi MC; Amar ID; Fiorelli A; Scambia G; Villa P
J Obstet Gynaecol; 2015; 35(8):835-8. PubMed ID: 25968636
[TBL] [Abstract][Full Text] [Related]
8. Role of high molecular weight hyaluronic acid in postmenopausal vaginal discomfort.
Grimaldi EF; Restaino S; Inglese S; Foltran L; Sorz A; Di Lorenzo G; Guaschino S
Minerva Ginecol; 2012 Aug; 64(4):321-9. PubMed ID: 22728576
[TBL] [Abstract][Full Text] [Related]
9. Effects of soy isoflavones on the concentration of hyaluronic acid in the vagina of type 1 diabetic rats.
F Carbonel AA; Azevedo Lima PD; Lim JJ; Teixeira Borges F; Rodrigues da Silva Sasso G; Portugal Fuchs LF; S Simões R; Chada Baracat E; Soares JM; J Simões M
Climacteric; 2017 Dec; 20(6):564-570. PubMed ID: 28866964
[TBL] [Abstract][Full Text] [Related]
10. Polycarbophil vaginal moisturizing gel versus hyaluronic acid gel in women affected by vaginal dryness in late menopausal transition: A prospective randomized trial.
Cagnacci A; Barattini DF; Casolati E; Pecoroni A; Mangrella M; Patrascu LC
Eur J Obstet Gynecol Reprod Biol; 2022 Mar; 270():239-245. PubMed ID: 35131532
[TBL] [Abstract][Full Text] [Related]
11. An alternative approach for the treatment of vaginal atrophy.
Quaranta L; Ottolina J; Parma M; Chionna R; Sileo F; Dindelli M; Origoni M; Candiani M; Salvatore S
Minerva Ginecol; 2014 Aug; 66(4):377-81. PubMed ID: 25020056
[TBL] [Abstract][Full Text] [Related]
12. Effect of raloxifene on sexual function in postmenopausal women.
Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
[TBL] [Abstract][Full Text] [Related]
13. Lasofoxifene enhances vaginal mucus formation without causing hypertrophy and increases estrogen receptor beta and androgen receptor in rats.
Wang XN; Simmons HA; Salatto CT; Cosgrove PG; Thompson DD
Menopause; 2006; 13(4):609-20. PubMed ID: 16837883
[TBL] [Abstract][Full Text] [Related]
14. Vaginal effects of ospemifene in the ovariectomized rat preclinical model of menopause.
Unkila M; Kari S; Yatkin E; Lammintausta R
J Steroid Biochem Mol Biol; 2013 Nov; 138():107-15. PubMed ID: 23665515
[TBL] [Abstract][Full Text] [Related]
15. A comparison between vaginal estrogen and vaginal hyaluronic for the treatment of dyspareunia in women using hormonal contraceptive.
Serati M; Bogani G; Di Dedda MC; Braghiroli A; Uccella S; Cromi A; Ghezzi F
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():48-50. PubMed ID: 26070127
[TBL] [Abstract][Full Text] [Related]
16. Effect of dehydroepiandrosterone on vaginal and uterine histomorphology in the rat.
Sourla A; Flamand M; Bélanger A; Labrie F
J Steroid Biochem Mol Biol; 1998 Aug; 66(3):137-49. PubMed ID: 9719448
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.
Cano A; Estévez J; Usandizaga R; Gallo JL; Guinot M; Delgado JL; Castellanos E; Moral E; Nieto C; del Prado JM; Ferrer J
Menopause; 2012 Oct; 19(10):1130-9. PubMed ID: 22914208
[TBL] [Abstract][Full Text] [Related]
18. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel.
Caruso S; Cianci S; Amore FF; Ventura B; Bambili E; Spadola S; Cianci A
Menopause; 2016 Jan; 23(1):47-54. PubMed ID: 26079974
[TBL] [Abstract][Full Text] [Related]
19. The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause.
Le Donne M; Caruso C; Mancuso A; Costa G; Iemmo R; Pizzimenti G; Cavallari V
Arch Gynecol Obstet; 2011 Jun; 283(6):1319-23. PubMed ID: 20577750
[TBL] [Abstract][Full Text] [Related]
20. Topical oxytocin reverses vaginal atrophy in postmenopausal women: a double-blind randomized pilot study.
Jonasson AF; Edwall L; Uvnäs-Moberg K
Menopause Int; 2011 Dec; 17(4):120-5. PubMed ID: 22120944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]